Finance

Lists
Why is MIRM up 3.27%?
Dive Deeper
MIRM:NASDAQ
Mirum Pharmaceuticals Inc
$95.51
+3.27%
(+3.02) 1D
$96.00
+0.51% (+0.49)
After hours
Closed: Nov 19, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MIRM...
Open
$92.57
High
$96.34
Low
$91.97
Mkt. cap
6.24B
Avg. vol.
646.64K
Volume
0.00
52-wk high
$130.00
52-wk low
$63.23
EPS
-$15.22
Beta
0.75
Shares outstanding
65.28M
No. of employees
470
Open
$92.57
High
$96.34
Low
$91.97
Mkt. cap
6.24B
Avg. vol.
646.64K
Volume
0.00
52-wk high
$130.00
52-wk low
$63.23
EPS
-$15.22
Beta
0.75
Shares outstanding
65.28M
No. of employees
470
News stories
From web sources and news partners
About Mirum Pharmaceuticals Inc
CEO-
Employees470
Founded2018
HeadquartersFoster City, California, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 12 analysts giving stock ratings to MIRM in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for MIRM in the last 3 months.
Highest
Current $95.51
$202.00 (+111.50%)
Average
$158.82 (+66.29%)
Lowest
$130.00 (+36.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$202.00
+111.5%
11/11/2026
Jessica Fye
J.P. Morgan
Buy
Maintained
-
-
11/09/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$194.00
+103.1%
11/11/2026
Joseph Schwartz
Leerink Partners
Buy
Maintained
$140.00
+46.6%
11/05/2026
Thomas Smith
Leerink Partners
Buy
Maintained
$140.00
+46.6%
11/05/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
$152.00
+59.1%
11/05/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
$156.00
+63.3%
11/04/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
$160.00
+67.5%
11/03/2026
Lisa Walter
RBC Capital
Buy
Reiterated
$155.00
+62.3%
11/03/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$167.00
+74.9%
11/04/2026
Joseph Thome
TD Cowen
Buy
Maintained
$145.00
+51.8%
11/03/2026
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
$195.00
+104.2%
10/22/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$146.00
+52.9%
10/13/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
$130.00
+36.1%
09/29/2026
Unknown Analyst
J.P. Morgan
Buy
Initiated
$115.00
+20.4%
05/20/2026
Kalpit Patel
Wolfe Research
Buy
Initiated
$145.00
+51.8%
05/19/2026
Mani Foroohar
Leerink Partners
Buy
Maintained
$154.00
+61.2%
05/15/2026
Ryan Deschner
Raymond James
Buy
Maintained
$165.00
+72.8%
05/07/2026
Joe Johoon Kim
RBC Capital
Buy
Maintained
$128.00
+34%
04/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
148.93M
159.88M
176.24M
185.72M
Cost of goods sold
28.26M
28.80M
30.35M
35.17M
Cost of revenue
28.26M
28.80M
30.35M
35.17M
Research and development expenses
51.11M
97.91M
90.53M
107.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74.13M
96.33M
81.47M
88.86M
Operating expense
125.24M
194.24M
172.00M
196.80M
Total operating expenses
153.50M
223.04M
202.34M
231.97M
Operating income
-4.57M
-63.16M
-26.10M
-46.25M
Other non operating income
-18.00K
102.00K
-11.14M
-165.00K
EBT including unusual items
-4.96M
-789.68M
-65.54M
-40.23M
EBT excluding unusual items
-4.96M
-64.38M
-36.21M
-43.23M
Income tax expense
767.00K
475.00K
1.69M
538.00K
Effective tax rate
-15.45%
-0.06%
-2.58%
-1.34%
Other operating expenses
-
-
-
-
Net income
-5.73M
-790.16M
-67.23M
-40.77M
Net profit margin
-3.85%
-494.21%
-38.14%
-21.95%
Earnings per share
-0.12
-1.08
-0.80
-0.42
Interest and investment income
3.42M
3.40M
3.85M
4.69M
Interest expense
-3.60M
-3.62M
-2.62M
-1.61M
Net interest expenses
-178.00K
-215.00K
1.23M
3.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.51M
-56.29M
-19.17M
-39.36M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps